Skip to main content
Moderna10-Q: Manufacturing issue

Sanofi sues Moderna, alleging patent infringement on COVID and RSV vaccine manufacturing.

What happened

A new lawsuit from competitor Sanofi SA, filed in July 2026, claims Moderna's core COVID and RSV vaccine products infringe on patents for mRNA delivery methods. This creates significant legal risk and potential disruption to Moderna's manufacturing and sales operations, increasing pressure to de-risk their processes and IP portfolio.

Source

SEC EDGARJul 31, 2026

Quarterly report (Form 10-Q)

Moderna 10-Q

Filing excerpt

In July 2026, Translate Bio, Inc., Translate Bio MA, Inc., Sanofi Vaccines US, Inc., and VaxServe, Inc. (all subsidiaries of Sanofi SA), filed a complaint against us in the U.S. District Court for the District of New Jersey asserting that our manufacture and sale of our COVID and RSV vaccines infringe U.S. patents related to compositions and methods for mRNA delivery.

sec.gov/Archives/edgar/data/1682852/000168285226000150/mrna-20260630.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Manufacturing issue

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end
06/30
Filed
Jul 31, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
1682852
Accession number
0001682852-26-000150
Timeframe
Current quarter
Filing year
2026
Fiscal year
0
Why it matters
Operations optimization needed
Signal category
Operations

Topics and mentions

Technologies

  • mRNA

Competitors

  • Sanofi SA

Extraction

Confidence
High
Relevance
90%
Sentiment
Negative
Detected
Aug 4, 2026
signal_type
sec-10q
signal_subtype
manufacturingIssue

Use this data

Get every 10-Q signal for Moderna and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/587d5d92-5efc-4ac9-b13c-f61bfd8e7dd8 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.

{
  "signal_id": "587d5d92-5efc-4ac9-b13c-f61bfd8e7dd8",
  "signal_type": "sec-10q",
  "signal_subtype": "manufacturingIssue",
  "detected_at": "2026-08-04T07:07:08.845+00:00",
  "company": {
    "name": "Moderna",
    "domain": "modernatx.com"
  },
  "data": {
    "detail": "A new lawsuit from competitor Sanofi SA, filed in July 2026, claims Moderna's core COVID and RSV vaccine products infringe on patents for mRNA delivery methods. This creates significant legal risk and potential disruption to Moderna's manufacturing and sales operations, increasing pressure to de-risk their processes and IP portfolio.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "summary": "Sanofi sues Moderna, alleging patent infringement on COVID and RSV vaccine manufacturing.",
    "excerpts": "In July 2026, Translate Bio, Inc., Translate Bio MA, Inc., Sanofi Vaccines US, Inc., and VaxServe, Inc. (all subsidiaries of Sanofi SA), filed a complaint against us in the U.S. District Court for the District of New Jersey asserting that our manufacture and sale of our COVID and RSV vaccines infringe U.S. patents related to compositions and methods for mRNA delivery.",
    "relevance": 0.9,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000150/mrna-20260630.htm",
    "filing_date": "2026-07-31",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "06/30",
    "sales_relevance": "Operations optimization needed",
    "signal_category": "operations",
    "competitors_mentioned": [
      "Sanofi SA"
    ],
    "technologies_mentioned": [
      "mRNA"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.